Cargando…

Efficacy and Safety of Andexanet Alfa for Bleeding Caused by Factor Xa Inhibitors: A Systematic Review and Meta-Analysis

Direct oral anticoagulants (DOAC) including factor Xa inhibitors are associated with bleeding events which can lead to severe morbidity and mortality. Reversal agents like andexanet alfa (AA) and 4F-PCC (Four-factor prothrombin concentrate complex) are available for treating bleeding that occurs wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Dhan B, Budhathoki, Pravash, Adhikari, Ayush, Shrestha, Sudat, Khati, Nirajan, Mir, Wasey Ali Yadullahi, Joshi, Tilak, Shrestha, Anuj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783383/ https://www.ncbi.nlm.nih.gov/pubmed/35103198 http://dx.doi.org/10.7759/cureus.20632

Ejemplares similares

An Adult Female Presenting With "Scrofula-Tubercular Lymphadenitis" a Rare Encounter: A Case Report
por: Sakhuja, Anuradha, et al.
Publicado: (2022)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Improving Medical Education: A Narrative Review
por: Joshi, Tilak, et al.
Publicado: (2021)

Team-Based Learning Among Health Care Professionals: A Systematic Review
por: Joshi, Tilak, et al.
Publicado: (2022)

Acotiamide and Functional Dyspepsia: A Systematic Review and Meta-Analysis
por: Shrestha, Dhan B, et al.
Publicado: (2021)

Granulomatosis With Polyangiitis: A Pauci-Immune Rapidly Progressive Glomerulonephritis With Isolated Renal Involvement in an Elderly Male
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Evaluation of oral factor Xa inhibitor‐associated extracranial bleeding reversal with andexanet alfa
por: Nederpelt, Charlie J., et al.
Publicado: (2020)

HIV Encephalopathy Mimicking Acute Demyelinating Processes
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes): A Case Report of a Rare Paraneoplastic Syndrome
por: Sakhuja, Anuradha, et al.
Publicado: (2022)

Institutional Experience of Using Andexanet Alfa
por: Khadka, Sushmita, et al.
Publicado: (2020)

Reversing factor Xa inhibitors – clinical utility of andexanet alfa
por: Kaatz, Scott, et al.
Publicado: (2017)

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
por: Carpenter, Elise, et al.
Publicado: (2019)

Aspergillosis: An Unwanted Tenant of Lung Cavity in an Immunocompromised Host
por: Sakhuja, Anuradha, et al.
Publicado: (2022)

Long-Term Favorable Outcome With Nivolumab in a Case of Advanced Non-Small Cell Lung Cancer: A Case Report
por: Reddy, Vijay Ketan, et al.
Publicado: (2021)

Rare Angina: A Case Report of Ludwig's Angina
por: Sakhuja, Anuradha, et al.
Publicado: (2022)

Scedosporium apiospermum Pneumonia in an Immunocompetent Host
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Pulmonary barotrauma in COVID-19: A systematic review and meta-analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2022)

Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
por: Bourdin, Matthieu, et al.
Publicado: (2021)

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
por: Stevens, Victoria M., et al.
Publicado: (2021)

Hypothermia versus normothermia after out-of-hospital cardiac arrest: A systematic review and meta-analysis of randomized controlled trials
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2022)

A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding
por: Jaspers, Tessa, et al.
Publicado: (2021)

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
por: Rauch, Sebastian, et al.
Publicado: (2022)

Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
por: Singer, Adam J., et al.
Publicado: (2023)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

A Rare Case of Right-Sided Aortic Arch With Mirror-Image Branching and Congenital Absence of the Left Pulmonary Artery
por: Shtembari, Jurgen, et al.
Publicado: (2023)

Concealed Malignancy as a Rare Cause of Refractory Lactic Acidosis: A Fatal Case
por: Khan Suheb, Mahammed Z, et al.
Publicado: (2021)

Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy
por: Demchuk, Andrew M., et al.
Publicado: (2021)

Utilizing the Most Accurate Preoperative Risk Calculator
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020)

Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018)

Urgent Endoscopic Retrograde Cholangiopancreatography (ERCP) vs. Conventional Approach in Acute Biliary Pancreatitis Without Cholangitis: An Updated Systematic Review and Meta-Analysis
por: Shrestha, Dhan B, et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation (ECMO) Dependent Acute Respiratory Distress Syndrome (ARDS): A Systematic Review and Meta-Analysis
por: Shrestha, Dhan B, et al.
Publicado: (2022)

Superior Sagittal Sinus Thrombosis in a Young, Immunocompetent HIV Patient: A Rare Case
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

A Case Report of Acute Transient Encephalopathy Following a Trans-esophageal Echocardiography
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

May-Thurner Syndrome: An Anatomic Predisposition to Deep Vein Thrombosis
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Heroin-Induced Leukoencephalopathy Leading to Locked-In Syndrome: A Case Report
por: Shtembari, Jurgen, et al.
Publicado: (2023)

Correction to: Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018)

Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
por: Benz, Alexander P., et al.
Publicado: (2022)

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center
por: Stevens, Victoria M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_32266j3n3dtm0i6sed3nosu8jj